Literature DB >> 16868554

Reduced oxidative stress promotes NF-kappaB-mediated neuroprotective gene expression after transient focal cerebral ischemia: lymphocytotrophic cytokines and antiapoptotic factors.

Yun Seon Song1, Yong-Sun Lee, Purnima Narasimhan, Pak H Chan.   

Abstract

Nuclear factor-kappa B (NF-kappaB) is activated by oxidative stress such as that induced by transient focal cerebral ischemia (tFCI). Whether NF-kappaB has a role in cell survival or death in stroke is a matter of debate. We proposed that the status of oxidative stress may determine its role in cell death or survival after focal ischemia. To characterize the coordinated expression of genes in NF-kappaB signaling after mild cerebral ischemia, we investigated the temporal profile of a NF-kappaB-pathway-focused DNA array after 30 mins of tFCI in wild-type (WT) mice and human copper/zinc-superoxide dismutase transgenic (SOD1 Tg) mice that had a significantly reduced level of superoxide. Differentially expressed genes among 96 NF-kappaB-related genes were further confirmed and compared in the WT and SOD1 Tg mice using quantitative polymerase chain reaction, Western blotting, and immunohistochemistry. Persistent upregulation of NF-kappaB seen at 7 days in the WT mice was decreased in the SOD1 Tg mice. Lymphocytotrophic cytokine genes such as interleukin-2, interleukin-12, and interferon-alpha1 were increased in the SOD1 Tg mice compared with the WT mice after tFCI. In addition, antiapoptosis factors bcl-2 and tumor necrosis factor receptor-associated factor 1 rapidly increased in the SOD1 Tg mice compared with the WT mice. This study indicates that reduced oxidative stress by SOD1 overexpression increased NF-kappaB-related rapid defenses, such as immune response and antiapoptosis factors, and prevented brain damage after tFCI-induced oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16868554      PMCID: PMC1831759          DOI: 10.1038/sj.jcbfm.9600379

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  57 in total

1.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome.

Authors:  C J Epstein; K B Avraham; M Lovett; S Smith; O Elroy-Stein; G Rotman; C Bry; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.

Authors:  U Hazan; D Thomas; J Alcami; F Bachelerie; N Israel; H Yssel; J L Virelizier; F Arenzana-Seisdedos
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  Upregulation of bax protein levels in neurons following cerebral ischemia.

Authors:  S Krajewski; J K Mai; M Krajewska; M Sikorska; M J Mossakowski; J C Reed
Journal:  J Neurosci       Date:  1995-10       Impact factor: 6.167

4.  Failure of FK-506, a new immunosuppressant, to prevent cerebral vasospasm in a canine two-hemorrhage model.

Authors:  K Nagata; T Sasaki; J Iwama; T Mori; S Iwamoto; H Nirei; K Hamada; T Kirino
Journal:  J Neurosurg       Date:  1993-11       Impact factor: 5.115

5.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.

Authors:  F Colotta; F Re; M Muzio; R Bertini; N Polentarutti; M Sironi; J G Giri; S K Dower; J E Sims; A Mantovani
Journal:  Science       Date:  1993-07-23       Impact factor: 47.728

Review 6.  The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

Authors:  F Colotta; S K Dower; J E Sims; A Mantovani
Journal:  Immunol Today       Date:  1994-12

7.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia.

Authors:  G Yang; P H Chan; J Chen; E Carlson; S F Chen; P Weinstein; C J Epstein; H Kamii
Journal:  Stroke       Date:  1994-01       Impact factor: 7.914

9.  Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

Authors:  K Brand; S Page; G Rogler; A Bartsch; R Brandl; R Knuechel; M Page; C Kaltschmidt; P A Baeuerle; D Neumeier
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

10.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.

Authors:  R Schreck; P Rieber; P A Baeuerle
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

View more
  16 in total

1.  Long-term neuroprotection from a potent redox-modulating metalloporphyrin in the rat.

Authors:  Huaxin Sheng; Wei Yang; Shiro Fukuda; Hubert M Tse; Wulf Paschen; Kwame Johnson; Ines Batinic-Haberle; James D Crapo; Robert D Pearlstein; Jon Piganelli; David S Warner
Journal:  Free Radic Biol Med       Date:  2009-07-22       Impact factor: 7.376

Review 2.  Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.

Authors:  Federico Carbone; Priscila Camillo Teixeira; Vincent Braunersreuther; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  Antioxid Redox Signal       Date:  2014-04-22       Impact factor: 8.401

Review 3.  Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection.

Authors:  Hai Chen; Hideyuki Yoshioka; Gab Seok Kim; Joo Eun Jung; Nobuya Okami; Hiroyuki Sakata; Carolina M Maier; Purnima Narasimhan; Christina E Goeders; Pak H Chan
Journal:  Antioxid Redox Signal       Date:  2011-01-09       Impact factor: 8.401

4.  Ischemic preconditioning mediates cyclooxygenase-2 expression via nuclear factor-kappa B activation in mixed cortical neuronal cultures.

Authors:  Eun Joo Kim; Ami P Raval; Nina Hirsch; Miguel A Perez-Pinzon
Journal:  Transl Stroke Res       Date:  2010-01-26       Impact factor: 6.829

Review 5.  NF-κB and innate immunity in ischemic stroke.

Authors:  Olivier A Harari; James K Liao
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

6.  Uric Acid Neuroprotection Associated to IL-6/STAT3 Signaling Pathway Activation in Rat Ischemic Stroke.

Authors:  Alicia Aliena-Valero; Sergio Rius-Pérez; Júlia Baixauli-Martín; Germán Torregrosa; Ángel Chamorro; Salvador Pérez; Juan B Salom
Journal:  Mol Neurobiol       Date:  2020-09-22       Impact factor: 5.590

7.  The role of Akt signaling in oxidative stress mediates NF-kappaB activation in mild transient focal cerebral ischemia.

Authors:  Yun Seon Song; Purnima Narasimhan; Gab Seok Kim; Joo Eun Jung; Eun-Hee Park; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-16       Impact factor: 6.200

Review 8.  Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia.

Authors:  Kuniyasu Niizuma; Hideyuki Yoshioka; Hai Chen; Gab Seok Kim; Joo Eun Jung; Masataka Katsu; Nobuya Okami; Pak H Chan
Journal:  Biochim Biophys Acta       Date:  2009-09-12

9.  NF-κB activation and cell death after intracerebral hemorrhage in patients.

Authors:  Zeli Zhang; Yuguang Liu; Qibing Huang; Yuxing Su; Yuan Zhang; Guanghui Wang; Feng Li
Journal:  Neurol Sci       Date:  2014-02-08       Impact factor: 3.307

10.  Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion.

Authors:  Hai Chen; Yun Seon Song; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-06       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.